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Abstract
Purpose Interstitial cystitis/bladder pain syndrome (IC/
BPS) is characterized by urinary urgency, frequency,
nocturia, pain worse as the bladder fills and improved after
emptying. These features might suggest abnormal auto-
nomic bladder control mechanisms. We compared the
structural integrity of the autonomic nervous system (ANS)
in IC/BPS and control subjects.
Methods IRB-approved study at University Hospitals
Case Medical Center, Cleveland, OH to evaluate the
structural integrity of the ANS in adult females. Testing
included cardiovascular response to deep breathing, Val-
salva maneuver, 30 min head up tilt, and sudomotor test.
Results Differences in ANS integrity for IC/BPS subjects
and controls were determined by modified Composite
Autonomic Severity Score (CASS) that includes sudomo-
tor, adrenergic and cardiovascular indices. Baseline heart
rate (HR) and HRs from each of three 10 min upright
segments of a tilt test were compared and trend analyses
performed using t tests. Healthy and IC/BPS subjects were
demographically similar. The two groups did not differ in
modified-CASS scores but elevated average peak heart rate
was evident during baseline (supine; p = 0.057) for IC/
BPS subjects prior to a tilt test. Difference at baseline was
maintained at each interval during the tilt, with nearly
identical slopes across intervals. The preliminary nature of
this report denotes a small sample size and important dif-
ferences may not be detected.
Conclusions The findings show no structural ANS
abnormalities in IC/BPS subjects. Higher baseline HR
supports the concept of functional rather than structural
change in the ANS, such as abnormality of sympathetic/
parasympathetic balance that will require further
evaluation.
Keywords Interstitial cystitis/bladder pain syndrome 
Pelvic pain  Autonomic nervous system
Introduction
Interstitial cystitis/bladder pain syndrome (IC/BPS) classi-
cally comprises urinary urgency, frequency, nocturia, and
chronic pain in the pelvis worse as the bladder fills and
better once empty. Such clinical features might suggest
disordered bladder control from a generalized autonomic
nervous system (ANS) abnormality. This concept might
explain the IC/BPS known comorbid conditions [5] such as
irritable bowel syndrome, migraine headache and fibro-
myalgia, also associated with ANS function changes [2, 6,
10, 13]. We hypothesized that IC/BPS belongs to a larger
family of (often co-morbid) disorders that share common
autonomic and sensory abnormalities. This study aimed to
assess the structural integrity of the ANS in subjects with
IC/BPS compared to healthy age matched controls. Based
on abnormalities reported in co-morbid disorders such as
fibromyalgia and migraine, we expected to find changes in
responses to sudomotor and tilt table testing, with preserved
G. Chelimsky  T. Chelimsky
Medical College of Wisconsin, 8701 W Watertown Plank Road,
Milwaukee, WI 53226, USA
N. P. McCabe  J. Janata  R. Elston  L. Zhang  S. Ialacci
Case Western Reserve University, 10900 Euclid Avenue,
Cleveland, OH 44106, USA
T. Chelimsky (&)
Department of Neurology, Medical College of Wisconsin,
9200 W. Wisconsin Ave., Milwaukee, WI 53226, USA
e-mail: tchelimsky@mcw.edu
123
Clin Auton Res (2014) 24:161–166
DOI 10.1007/s10286-014-0243-0
cardiovascular responses to deep breathing and to the Val-
salva maneuver. In addition, given the changes in heart rate
variability found by others in chronic pain states, we
thought it important to evaluate the structure of the ANS as
a basis for drawing any conclusions regarding its structure.
Participants and methods
Participants
This prospective IRB-approved study (University Hospi-
tals Case Medical Center, Cleveland, OH) conducted in
accordance with the ethical standards laid down in the
1964 Declaration of Helsinki and its later amendments
evaluated the structural integrity of the ANS of adult
females with diagnosis of IC/BPS and matched female
healthy controls, as a portion of the larger ICEPAC
(Interstitial Cystitis—Elucidation of Psychophysiologic
and Autonomic Characteristics) study (ClinicalTrials.gov
Identifier: NCT01616992). Data presented herein are from
women enrolled in ICEPAC between 02/2011 and 02/2012
recruited through University Hospitals Case Medical
Center (Cleveland, OH), and Case Western Reserve Uni-
versity (Cleveland, OH), Summa Health System (Akron,
OH), and ResearchMatch.org. All subjects gave their
informed consent prior to inclusion in the study. Study
enrollment continues through June of 2014 with a goal of
38 healthy and 76 IC/BPS participants. Other ICEPAC
subject groups are not presented here.
Inclusion/exclusion criteria
Subjects with IC/BPS required C6 months of symptoms
with pain clearly linked to bladder fullness, and exclusion
criteria aligned with the IC/BPS-NIDDK criteria [1].
Healthy controls consisted of matched females, screened to
exclude the presence of both IC/BPS and any manifestation
(in the last 5 years) of any disorder commonly co-morbid
with IC/BPS, including fibromyalgia by history or exam,
chronic fatigue syndrome or unexplained fatigue for
[6 months, chronic pain disorder of any type, complex
regional pain syndrome, cyclic vomiting syndrome, irrita-
ble bowel syndrome, functional abdominal pain, functional
dyspepsia, migraine headache, postural tachycardia syn-
drome, Raynaud’s syndrome, reflex syncope, temporo-
mandibular joint disorder, post-traumatic stress disorder,
panic disorder, periodic limb movements in sleep, and
multiple chemical sensitivity. Exclusion criteria for all
subjects (healthy and IC/BPS) included pregnancy,
breastfeeding, hematuria or infection on urinalysis, three
urinary tract infections within the previous 12 months,
pelvic or bladder neoplasm or infection, unstable medical
or psychiatric illness (such as untreated depression, psy-
chosis, etc.), central or peripheral nervous system disorder
(Diabetic Neuropathy—regardless of A1c level, Parkin-
son’s disease, Alzheimer’s, MS, stroke, etc.), inability to
stop autonomically active or pro-kinetic (gastrointestinal
motility modifying) agents prior to testing, current con-
sumption of [10 alcoholic beverages per week, or any
major surgical intervention in the last 90 days.
Autonomic testing
All subjects underwent ANS testing described in detail
elsewhere [3] including the cardiovascular responses to
deep breathing (DB, primarily testing cardiac parasympa-
thetic integrity), the Valsalva maneuver (VM, testing car-
diac sympathetic, parasympathetic and vasomotor
sympathetic integrity), tilt table test (testing cardiac and
vasomotor sympathetic integrity) and quantitative sudo-
motor axon reflex test (QSART, testing post-ganglionic
sympathetic cholinergic integrity). The tilt table test was
performed at 70 for 30 min. The VM (using 15 s and
40 mmHg) and DB were performed 3 and 2 times,
respectively, in each subject.
Evaluation and statistical analyses
To quantify the results of testing, we utilized a modified
Composite Autonomic Severity Score (CASS) [11]
Table 1 Modified Composite Autonomic Severity Score (CASS)
Sudomotor index Single QSART site reduced or distal sweat
volume \1/3 of proximal value
Single QSART site \50 % of lower limit
Two or more QSART sites \50 % of limit
Adrenergic index Phase IIE reduction \40 [25 mmHg MBP, or
reduced phase IIL, or pulse pressure reduction
to B50 % of baseline
Increased PRT time (4–5 s)
Phase IIL absent or increased PRT (6–9 s)
Absent phase IV
Absent phase IIL and IV and increased PRT
C10 s
The prior one plus orthostatic hypotension




HRDB or VR reduced but [50 % of minimum
HRDB or VR reduced but \50 % of minimum
HRDB and VR reduced but \50 % of minimum
Each subsection allows for 1 score point (i.e. a total of 3 for sudo-
motor, 4 for adrenergic and 3 for cardiovascular HR index)
QSART quantitative sudomotor axon reflex, MBP mean blood pres-
sure, PRT pressure recovery time, SBP systolic blood pressure, HRDB
heart rate response to deep breathing, VR valsalva ratio
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(Table 1), with sudomotor, adrenergic and cardiovascular
heart rate indices. Some degree of anxiety may artificially
inflate initial baseline pressures and heart rates, producing
a false impression of an orthostatic drop. The tilt table
test baseline was therefore taken from the last 3 min of
the 5–10 min segment after return to the supine position,
except if tilt table test was terminated due to a near-
syncopal episode, when a strong vagal surge may produce
a non-typical post-tilt baseline, and the baseline was taken
from the final 3 min of the first 10 min supine period
prior to upright tilt. The upright portion of the tilt was
divided in three 10-min segments with the mean of the
three highest heart rates taken as the peak for each seg-
ment. Activity and symptom severity were evaluated
every minute during the tilt table test, and outliers
accompanying fidgeting and talking were excluded. Sub-
jects unable to complete the first two intervals of the tilt
table test (e.g. due to a syncopal episode) were excluded
from HR analysis.
Data Analysis asked several questions: (1) Do IC/BPS
and healthy control HR differ at baseline or when
upright? (2) Is there an upright trend? (3) If a trend is
found, is it linear or quadratic and is there a between
group difference in that trend? Each of these questions
was answered by calculating a linear contrast of the
observed average peak HR for each of the subjects in the
sample and performing a t test. Since the average peak
HR values and log-transformed values produced similar
results, only the average peak HR values are shown. Age,
BMI and modified CASS score between groups were also
compared by t test.
Results
This preliminary report includes 15 healthy women [mean
age 36.3 years ± 16.1 (SD); mean BMI 26.7 ± 8.6] and
14 women with IC/BPS (mean age 36.5 years ± 16.1;
mean BMI 29.0 ± 7.7). There was no significant differ-
ence in age (p = 0.98) or BMI (p = 0.46) between healthy
and IC/BPS subjects. The analysis included two subjects
with IC/BPS that were unable to stop medications (one was
on diphenhydramine and the other on amitriptyline). The
subject on amitriptyline had a modified CASS score of 3,
with 2 points due to decreased sweat in the foot and 1 point
for mild adrenergic dysfunction during the Valsalva
maneuver, with no syncope and HR increased during the
tilt of \10 bpm while upright. The subject on diphenhy-
dramine had a modified CASS of 3 due to significant
decrease in sweat output in the forearm and foot, with
normal adrenergic and cardiovascular HR index, and HR
increased by 33 bpm while upright prior to a pre-syncopal
episode. As the results from these two subjects did not
differ significantly from the other subjects, they were
included for analysis. No significant difference was
observed between women with IC/BPS and healthy con-
trols for any ANS integrity test as indicated by total
modified CASS scores (Table 2). Three subjects with
syncopal episodes in the first 20 min were excluded from
the tilt table test analysis.
Cardiovascular response
Cardiac response to deep breathing was abnormal in three
IC/BPS and in one healthy control. One healthy subject and
one IC/BPS had a mildly abnormal Valsalva HR ratio. The
cardiovascular HR index and the adrenergic index were
similar in both groups (Table 2).
Tilt table test
All subjects underwent a tilt table test. Two IC/BPS sub-
jects failed to complete interval 3; one fainted 1 min into
interval 3 and one complained of discomfort 4 min into
interval 3 and the tilt was discontinued. Two subjects in the
healthy group and 3 in the IC/BPS had pre-syncope.
Orthostatic hypotension did not occur. A difference in
baseline HR (supine) between the groups approached sig-
nificance (p = 0.057) and there is a significant linear trend
after baseline, with no significant non-linear trend or trend
by group interaction (Table 3; Fig. 1). Log transformation
produced similar results with a slightly lesser fit (not
shown). The t tests are not independent but the correlation
between contrasts for baseline and slope were not
significant.
Quantitative sudomotor axon reflex test (Qsart)
Subjects in the healthy control and in the IC/BPS groups
showed mild abnormalities of sudomotor function, with
comparable modified sudomotor CASS scores (Table 2).
Table 2 Summary of autonomic testing findings
IC/BPS Healthy p
Number of subjects 14 15




Sudomotor index 1.8 ± 1.3 1.4 ± 1.0 [0.05
Adrenergic index 0.6 ± 0.5 0.5 ± 0.5 [0.05
CV HR index 0.2 ± 0.4 0.1 ± 0.4 [0.05
Modified CASS 2.4 ± 1.4 2.0 ± 1.1 [0.05
Values are mean ± SD
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Discussion
To our knowledge, this is the first study to assess ANS
integrity in patients with IC/BPS. While these data are
preliminary, the aim of this manuscript was to evaluate the
data accumulated to date and generate hypotheses that
could be tested in the complete dataset. The ICEPAC study
was designed to test the hypothesis that ANS structure may
be abnormal in IC/BPS. Our data to date suggest that the
null hypothesis prevails, i.e. that the structure of the ANS,
at least as it innervates cardiovascular and sudomotor end-
organs, is normal as evaluated by standard clinical auto-
nomic testing.
To date, several studies have assessed various aspects of
the ANS in a variety of painful disorders, for example heart
rate variability in fibromyalgia [15] or irritable bowel
syndrome [2] or heart rate and blood pressure change to
bladder filling in IC/BPS [16]. However, none of these
studies had undertaken the critical preliminary step of
determining whether the structure of the ANS is intact.
Without this information, one could not determine whether
findings of abnormal ANS activity might be due to a
structural change in the ANS, or to a functional abnor-
mality associated with the disorder being studied. The
current findings indicate that ANS structure in these
patients does not differ from that of healthy matched
Table 3 Summarized data from
the tilt table test
Peak HR data presented as
mean ± SD
a IC/BPS minus healthy control
b Data were pooled (healthy
control and IC/BPS) as there was
no difference between the fitted
lines for each group. This created
a model for all data post baseline
IC/BPS Healthy Estimate p 95 % CI
Number of subjects 12 13
Baseline
Peak HR 72.17 ± 15.44 62.08 ± 7.48
Group differencea 10.09 0.057 (-0.352, 20.53)
Post baseline
Peak HR interval 1 90.50 ± 20.83 79.85 ± 13.28 0.148
Peak HR interval 2 95.67 ± 24.08 81.38 ± 13.04 0.086
Peak HR interval 3 98.58 ± 25.02 85.54 ± 13.88 0.104
Group differencea 12.99 0.106 (-3.050, 29.038)
Linear slope (pooled)b 3.16 \0.0001 (1.876, 4.445)
Linear slope by group
interaction (non-pooled)
1.70 0.186 (-0.887, 4.278)
Quadratic curvature
(pooled)b




-1.93 0.181 (-4.833, 0.968)
Fig. 1 Mean peak heart rate data at baseline (interval 0) and during
the first, second, and third 10-min blocks (intervals 1, 2, and 3,
respectively) of the upright tilt. a Slopes of post-baseline trends for
healthy controls and subjects with IC/BPS. Data are mean peak heart
rate ± SE. b Raw mean peak HR data points for each group at their
respective intervals
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females at least in IC/BPS, suggesting that observed ANS
differences more likely relate to functional, not structural
abnormalities. The observed increase in the baseline heart
rate, as well as a trend for increased heart rate after 10 min
upright, support a tentative conclusion of an abnormality in
ANS responsiveness and function, rather than any struc-
tural change in the autonomic fibers or connections them-
selves. This hypothesis will be further explored in separate
studies focused on ANS function, using heart rate vari-
ability analysis.
It is important to note that our healthy control group, despite
being highly selected by history (previous 5 years) and
detailed examination to confirm the absence of any signs or
symptoms suggestive of a chronic pain, autonomic or neuro-
logic disorder, did demonstrate some mild abnormalities. Such
findings challenge our understanding of ‘‘normal’’ [4]. More-
over, these ‘‘abnormal’’ values may have obscured differences
between the groups. Alternatively, the absence of a difference
may simply represent a type II error—a larger cohort would
demonstrate a difference. The subjects with IC/BPS that could
not stop medication may have augmented abnormalities
associated with the tilt test and autonomic testing due to anti-
cholinergic properties of diphenhydramine and amitriptyline.
However, these medications should have increased, not
decreased, the difference between the groups [7, 9].
Studies of the ANS in patients with IC/BPS are scarce.
One recent study found that hydrodistention of the urinary
bladder induced a much greater heart rate, systolic and
diastolic blood pressure rise in subjects with and without
cystoscopic findings of ulcers and/or submucosal petechial
hemorrhages [16]. The authors mentioned several possible
interpretations, including (1) increased (although not
reported) pain sensation in patients with ulcers; (2) dif-
ferent stages of the same disease or (3) two different dis-
eases. Subjects with IC/BPS also have been shown to have
increased baseline heart rate at rest when compared to
controls, as well as some increase in the resting diastolic,
but not the systolic, blood pressure [12]. We have found
similar results, with higher baseline heart rate in the IC/
BPS patients. However, in none of these studies had the
structure of the ANS also been evaluated. The findings
from our study lend credence to the idea that one can
reliably examine ANS function in these patients. The
increase in heart rate may be related to several factors: (1)
amount of physical activity subjects are performing; (2) a
functional rather than a structural change in the ANS such
as an abnormality of sympathetic/parasympathetic balance
suggested by our finding and that of others [12, 16], leading
to a higher baseline heart rate; (3) higher anxiety level. The
findings in this hypothesis generating study will allow
further exploration of these possibilities.
This is not the first study to report a change in auto-
nomic function in patients with a chronic pain disorder. A
relative skew toward sympathetic influence also occurs in
other functional pain disorders such as irritable bowel
syndrome, fibromyalgia and chronic fatigue [2, 8, 14]. To
date, no study has examined the meaning of these findings
in the context of pain generating mechanisms to understand
whether increased heart rate, for example, reflects a con-
tributor or a consequence of a chronic pain syndrome. A
prospective study will clarify the role of the ANS in
chronic pelvic pain, and its relationship to psychological
changes that occur frequently in these disorders. Future
directions might include an assessment of heart rate vari-
ability at rest and after a physiologic or psychological
stress or to extend the findings reported by Lutgendorf et al.
[12].
In conclusion, although this study was performed in a
relatively small number of subjects (n = 29), which could
lead to a type II error (not finding a difference when one
exists) it nonetheless constitutes the largest study of the
ANS in IC/BPS to date. These findings require confirma-
tion with a larger cohort, but suggest that ANS structure is
not different in subjects with IC/BPS when compared to
highly screened healthy subjects. Particular note should be
made that this detailed screening of normal subjects
required healthy subjects to have no disorders of any kind
remotely known to harbor an association with any auto-
nomic abnormality. Nonetheless, occasional mild abnor-
malities were present.
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